- Home
- PLTK vs VCEL Comparison
PLTK vs VCEL Comparison
Compare PLTK & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLTK | VCEL |
|---|---|---|
| Founded | 2010 | 1989 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 2.0B |
| IPO Year | 2021 | 1997 |
Fundamental Metrics
Financial Performance| Metric | PLTK | VCEL |
|---|---|---|
| Price | $4.12 | $36.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 6 |
| Target Price | $6.61 | ★ $60.40 |
| AVG Volume (30 Days) | ★ 954.0K | 611.4K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | ★ 9.80% | N/A |
| EPS Growth | N/A | ★ 236.54 |
| EPS | 0.23 | ★ 0.25 |
| Revenue | ★ $2,726,900,000.00 | $258,716,999.00 |
| Revenue This Year | $9.52 | $17.86 |
| Revenue Next Year | $2.76 | $18.55 |
| P/E Ratio | ★ $17.65 | $147.60 |
| Revenue Growth | 7.49 | ★ 14.05 |
| 52 Week Low | $3.31 | $29.24 |
| 52 Week High | $7.58 | $63.00 |
Technical Indicators
Market Signals| Indicator | PLTK | VCEL |
|---|---|---|
| Relative Strength Index (RSI) | 51.26 | 43.93 |
| Support Level | $4.07 | $34.79 |
| Resistance Level | $4.42 | $37.11 |
| Average True Range (ATR) | 0.13 | 1.43 |
| MACD | -0.02 | -0.32 |
| Stochastic Oscillator | 27.38 | 22.61 |
Price Performance
Historical ComparisonAbout PLTK Playtika Holding Corp.
Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. It offers both Mobile and Web-based platforms.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.